It is a research & development private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 | Mumbai, Maharashtra, India | Struck OffAvaan Therapeutics India Private Limited, a struck off private limited company, was established on 29 January 2008 in Mumbai, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100MH2008PTC178339. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Veena Rani Mishra (Director), Amit Jagdish Negandhi (Additional Director). Past directors included Rajnish Mishra, Dilip Jayantilal Mehta, Anil Jayantilal Mehta. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at 62 Deonar House Deonar Village, Mumbai, Maharashtra, 400088.
U73100MH2008PTC178339
178339
29 January 2008
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Avaan Therapeutics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Rani Mishra | Director | 29 Jan 2008 | Current |
| Amit Jagdish Negandhi | Additional Director | 18 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 May 2017 | Past |
| Pramod Abcsdd | Director | 19 May 2017 | Past |
| Pramod Abcsdd | Director | 19 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avaan Therapeutics India Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2016, Avaan Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Avaan Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avaan Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avaan Therapeutics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Amit Jagdish Negandhi was appointed as a Additional Director was appointed as a Additional Director on 18 May 2017 & has been associated with this company since 8 years 7 months . was documented.
Progress on Avaan Therapeutics India Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was documented.
Avaan Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was recorded as a recent event.
Progress on Veena Rani Mishra was appointed as a Director was appointed as a Director on 29 Jan 2008 & has been associated with this company since 17 years 10 months . was documented.
The activity Avaan Therapeutics India Private Limited was registered on 29 Jan 2008 with Roc Mumbai & aged 17 years 10 months as per MCA records. was completed.
The CIN of Avaan Therapeutics India Private Limited is U73100MH2008PTC178339.
Avaan Therapeutics India Private Limited is headquartered at 62 Deonar House Deonar Village, Mumbai, Maharashtra, 400088.
Avaan Therapeutics India Private Limited was incorporated on 29 January 2008.
The current directors of Avaan Therapeutics India Private Limited are
The primary industry of Avaan Therapeutics India Private Limited is Research & Development.
Avaan Therapeutics India Private Limited is unlisted.
The authorized capital of Avaan Therapeutics India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX